Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Am J Physiol Gastrointest Liver Physiol. 2022 Feb 1;322(2):G234-G246. doi: 10.1152/ajpgi.00254.2021. Epub 2021 Dec 23.
The fibrogenic wound-healing response in liver increases stiffness. Stiffness mechanotransduction, in turn, amplifies fibrogenesis. Here, we aimed to understand the distribution of stiffness in fibrotic liver, how it impacts hepatic stellate cell (HSC) heterogeneity, and identify mechanisms by which stiffness amplifies fibrogenic responses. Magnetic resonance elastography and atomic force microscopy demonstrated a heterogeneous distribution of liver stiffness at macroscopic and microscopic levels, respectively, in a carbon tetrachloride (CCl) mouse model of liver fibrosis as compared with controls. High stiffness was mainly attributed to extracellular matrix dense areas. To identify a stiffness-sensitive HSC subpopulation, we performed single-cell RNA sequencing (scRNA-seq) on primary HSCs derived from healthy versus CCl-treated mice. A subcluster of HSCs was matrix-associated with the most upregulated pathway in this subpopulation being focal adhesion signaling, including a specific protein termed four and a half LIM domains protein 2 (FHL2). In vitro, FHL2 expression was increased in primary human HSCs cultured on stiff matrix as compared with HSCs on soft matrix. Moreover, FHL2 knockdown inhibited fibronectin and collagen 1 expression, whereas its overexpression promoted matrix production. In summary, we demonstrate stiffness heterogeneity at the whole organ, lobular, and cellular level, which drives an amplification loop of fibrogenesis through specific focal adhesion molecular pathways. The fibrogenic wound-healing response in liver increases stiffness. Here, macro and microheterogeneity of liver stiffness correlate with HSC heterogeneity in a hepatic fibrosis mouse model. Fibrogenic HSCs localized in stiff collagen-high areas upregulate the expression of focal adhesion molecule FHL2, which, in turn, promotes extracellular matrix protein expression. These results demonstrate that stiffness heterogeneity at the whole organ, lobular, and cellular level drives an amplification loop of fibrogenesis through specific focal adhesion molecular pathways.
肝脏的纤维生成性愈合反应会增加硬度。反过来,硬度机械转导会放大纤维化。在这里,我们旨在了解纤维化肝脏中硬度的分布方式、它如何影响肝星状细胞 (HSC) 的异质性,以及确定硬度放大纤维生成反应的机制。磁共振弹性成像和原子力显微镜分别在四氯化碳 (CCl) 诱导的小鼠肝纤维化模型和对照中,在宏观和微观水平上证明了肝脏硬度的异质性分布。高硬度主要归因于细胞外基质密集区。为了鉴定对硬度敏感的 HSC 亚群,我们对源自健康对照和 CCl 处理小鼠的原代 HSC 进行了单细胞 RNA 测序 (scRNA-seq)。HSC 的一个亚群与细胞外基质相关,该亚群中上调最明显的途径是焦点黏附信号通路,包括一种特定的蛋白质,称为四个半 LIM 结构域蛋白 2 (FHL2)。在体外,与软基质相比,在刚度较大的基质上培养的原代人 HSC 中 FHL2 的表达增加。此外,FHL2 敲低抑制纤连蛋白和胶原蛋白 1 的表达,而其过表达则促进基质生成。总之,我们证明了整个器官、小叶和细胞水平的硬度异质性,这通过特定的焦点黏附分子途径放大了纤维化的放大环。肝脏的纤维生成性愈合反应会增加硬度。在这里,肝硬度的宏观和微观异质性与肝纤维化小鼠模型中的 HSC 异质性相关。定位于硬胶原丰富区的纤维生成性 HSC 上调焦点黏附分子 FHL2 的表达,进而促进细胞外基质蛋白的表达。这些结果表明,整个器官、小叶和细胞水平的硬度异质性通过特定的焦点黏附分子途径驱动纤维化的放大环。